scispace - formally typeset
J

John M. Pach

Researcher at Mayo Clinic

Publications -  26
Citations -  3939

John M. Pach is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Retinopathy & Diabetes mellitus. The author has an hindex of 16, co-authored 26 publications receiving 3680 citations.

Papers
More filters
Journal Article

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort

TL;DR: Two thirds of diabetic patients have objective evidence for some variety of neuropathy, but only about 20% have symptoms, and only 6% of IDDM and only 1% of NIDDM patients have sufficiently severe polyneuropathy to be graded stage 2b, and none were graded stage 3.
Journal ArticleDOI

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort The Rochester Diabetic Neuropathy Study

TL;DR: The magnitude of the health problem from diabetic neuropathies remains inadequately estimated due to the lack of prospective population-based studies employing standardized and validated assessments of the type and stage of neuropathy as compared with background frequency.
Journal ArticleDOI

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and complications trial

Neil H. White, +324 more
TL;DR: The persistent difference in diabetic retinopathy between former intensive and conventional therapy ("metabolic memory") continues for at least 10 years but may be waning.
Journal ArticleDOI

Structure and Function of the Corneal Endothelium in Diabetes Mellitus Type I and Type II

TL;DR: The corneas of patients with type I diabetes mellitus exhibit abnormalities in endothelial cell morphologic characteristics and corneal autofluorescence that resemble those that occur with aging in normal subjects, making them difficult to discern as abnormal in type II diabetics, who are usually older.